TITLE

New alternatives in the N.H.S. II. What advances in treatment can we afford? Criteria for introducing technical advance

AUTHOR(S)
Rhodes, P
PUB. DATE
November 1974
SOURCE
British Medical Journal;11/9/1974, Vol. 4 Issue 5940, p327
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64112193

 

Related Articles

  • General principles of chemotherapy. RICEVUTO, E.; BRUERA, G.; MARCHETTI, P. // European Review for Medical & Pharmacological Sciences;2010, Vol. 14 Issue 4, p269 

    Background and Objective: Over the last 50 years, medical treatment of solid cancers gained major advances in terms of effectiveness through breakthrough knowledge of cancer biology, technology development and identification of fundamental active drugs. State of the Art: We conventionally...

  • General principles of chemotherapy. RICEVUTO, E.; BRUERA, G.; MARCHETTI, P. // European Review for Medical & Pharmacological Sciences;2010, Vol. 14 Issue 6, p268 

    Background and Objective: Over the last 50 years, medical treatment of solid cancers gained major advances in terms of effectiveness through breakthrough knowledge of cancer biology, technology development and identification of fundamental active drugs. State of the Art: We conventionally...

  • NICE tackles the challenge of cancer treatments.  // PharmacoEconomics & Outcomes News;2/7/2009, Issue 571, p2 

    The article reports on the new criteria for the appraisal of end-of-life cancer treatments introduced by the Great Britain National Institute of Clinical Excellence (NICE) in 2009. Drugs must meet specific criteria such as a small treatment population, a short life expectancy, ability to extend...

  • QUALITY CRITERIA FOR CARDIAC IMAGES: AN UPDATE. Bernardi, A.; Bar, G.; Jezewski, T.; Vano, E.; Maccia, C.; Trianni, A.; Padovani, R. // Radiation Protection Dosimetry;2008 Special Issue, Vol. 129 Issue 1-3, p87 

    The DIMOND II and III Cardiology Groups have agreed on quality criteria for cardiac images and developed a scoring system, to provide a tool to test quality of coronary angiograms, which was demonstrated to be of value in clinical practice. In the last years, digital flat panel technology has...

  • NHS patients to get new MS drug.  // Daily Mail;5/28/2014, p27 

    A NEW treatment for multiple sclerosis that not only stops the disease from advancing but may help reverse disability has been approved for use on the NHS.

  • REANASTOMOSIS TUBÁRICA POR VÍA LAPAROSCÓPICA. Escalona, M. Juan Raúl; Rabischong, Benoît; Nohuz, Erdogan; Moraga, P. Ana María // Revista Chilena de Obstetricia y Ginecología;2006, Vol. 71 Issue 2, p104 

    Background: Tubal ligation is used in a large number of young patients, who frequently want a new pregnancy, the percentage rate ranges from 1.3 to 15%. Until now the standard treatment has been the microsurgical tubal anastomosis through laparotomy, however, the development of new techniques...

  • Existence and Global Exponential Stability of Equilibrium for Impulsive Cellular Neural Network Models with Piecewise Alternately Advanced and Retarded Argument. Kuo-Shou Chiu // Abstract & Applied Analysis;2013, p1 

    We introduce impulsive cellular neural network models with piecewise alternately advanced and retarded argument (in short IDEPCA).Themodel with the advanced argument is systemwith strong anticipation. Some sufficient conditions are established for the existence and global exponential stability...

  • Toward a statistically explicit understanding of de novo sequence assembly. Howison, Mark; Zapata, Felipe; Dunn, Casey W. // Bioinformatics;Dec2013, Vol. 29 Issue 23, p2959 

    Motivation: Draft de novo genome assemblies are now available for many organisms. These assemblies are point estimates of the true genome sequences. Each is a specific hypothesis, drawn from among many alternative hypotheses, of the sequence of a genome. Assembly uncertainty, the inability to...

  • What is wrong with NHS leadership development? Edmonstone, John // British Journal of Healthcare Management;Nov2013, Vol. 19 Issue 11, p531 

    2014 will see the advent of a new fast-track leadership development scheme (costing some £10 million) for the NHS in England which aims to combine development for senior NHS clinicians with advancement for managers from outside the NHS. Following completion of this 10-month programme the...

  • Editorial. Witzmann, Frank; Mu Wang // Briefings in Functional Genomics & Proteomics;May2005, Vol. 4 Issue 1, p5 

    Introduces a series of articles related to technical advances and applications of various proteomic approaches.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics